| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_33c922e05f6133b7d72dbb849d77487d |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0053
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P15-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P3-04 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-5377
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P29-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P15-10 |
| filingDate |
2021-12-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8ef22993c21c114183304d25ddb4376f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_eaf79006985a667c1488cf14fda9d5a1
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_192c1320483b3d094841c14fb96937e7
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7d5840ee9f1c028fe2e8b98ece423ffa
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_ead5a5ee5bea9913073282c1536cf4b9 |
| publicationDate |
2022-06-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-20220090450-A |
| titleOfInvention |
Use as melanocortin-4 receptor selective agonist |
| abstract |
The present invention relates to the use of a compound of Formula 1 or a pharmaceutically acceptable salt thereof as a selective agonist of melanocortin-4 receptor (MC4R): [Formula 1] In Formula 1, R1 is C 2 -C 5 alkyl. |
| priorityDate |
2020-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |